ORTEXORTEX News
Tracking FOUR? Get live short interest, options flow, and signals on ORTEX.Sign up free →
FO
ConfluenceFOUR

FOUR: Borrow Market Freezes as Calls Surge

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 26 Jun 2026, 13:15

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit
ORTEX chart of Shift4 Payments, Inc. (FOUR) share price and short interest (% of free float), three months to June 25, 2026
ORTEX data as of 26 Jun 2026, 13:15

Shift4 Payments is caught in a rare crossfire. Short interest sits at 24.9% of free float. Borrow availability has all but vanished. Yet options traders are piling into calls at the most aggressive pace in over a year.

The Borrow Market Has Closed

Availability on FOUR collapsed to 0.16% on June 24 — the tightest reading in 52 weeks. Only one share remained available for every 600 already borrowed. As of June 25, it has recovered marginally to 3.6%, but the signal is clear: this borrow market is essentially frozen.

Short interest rose 13.6% in a single day, reaching 24.9% of free float. The official FINRA figure, settled June 15, already showed 16.7 million shares short with 8.75 days to cover. The ORTEX daily estimate now puts shares short at 16.85 million. That's a meaningful build in a stock trading near $43.78.

The ORTEX short score stands at 79.7 — and has crept higher every session this week. The factor rank for utilization sits at 1 out of 100, the most extreme percentile possible.

Calls Are Dominating

The put-call ratio hit 0.477 on June 25. That's 2.78 standard deviations below the 20-day mean of 0.508. For context, the PCR had sat in a narrow band between 0.50 and 0.52 for most of the past six weeks. The break lower is abrupt.

The move came on the back of a 14% single-day rally on June 24. Options traders responded by loading calls — a sharp reversal from the steady, bearish positioning that had defined the prior month. The 52-week PCR low is 0.197, so there is room to run further toward call dominance.

Analyst Consensus Still Cautious

Loop Capital initiated coverage on June 25 with a Hold and a $40 target — below the current price. That's a pointed entry. Truist cut its target to $46 from $50 last month. DA Davidson and RBC both trimmed targets in May, though both kept bullish-to-outperform ratings.

The consensus sits at Hold. The mean price target is $60.14 — still 37% above current levels. But the recent initiation from Loop at $40 captures the bear view clearly: the stock is trading near fair value at best.

Founder Jared Isaacman bought nearly 388,500 shares in May alone, spending roughly $16 million combined across two purchases. Net insider buying over 90 days totals $18.2 million. That's a forceful counter-signal to the short conviction.

Data Summary

  • Short interest: 24.9% of free float, up 13.6% in one day
  • Borrow availability: 3.6% (hit 0.16% on June 24 — 52-week low)
  • Days to cover (FINRA): 8.75
  • ORTEX short score: 79.7 (ranked 1st percentile for utilization)
  • Put-call ratio: 0.477 — 2.78 std devs below 20-day mean
  • Analyst consensus: Hold; mean target $60.14; Loop Capital initiates at $40
  • Net insider buying (90d): $18.2 million, led by founder Jared Isaacman
  • Next earnings: August 5, 2026

Against its own history

This week's change in short interest is 3.0 standard deviations above the company's typical weekly move over the past year.

Against its peers

Shares moved +11.1% over the past week against a median of -0.0% for its closest peers.

Stocks in this article

See the live data behind this article on ORTEX.

Open FOUR on ORTEX →

How this article was generated

Generated
26 Jun 2026, 13:21
Data as of
26 Jun 2026, 13:15
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.